U.S. Physical Therapy (NYSE:USPH) Price Target Lowered to $98.00 at Barrington Research

U.S. Physical Therapy (NYSE:USPH) had its target price lowered by Barrington Research from $108.00 to $98.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

A number of other research firms also recently weighed in on USPH. JMP Securities started coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They set an “outperform” rating and a $113.00 price target for the company. JPMorgan Chase & Co. raised their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their price target for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday. Finally, Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and an average target price of $111.50.

U.S. Physical Therapy Stock Down 1.6 %

Shares of U.S. Physical Therapy stock opened at $81.08 on Friday. The stock has a 50-day moving average price of $88.41 and a 200 day moving average price of $87.67. The company has a market cap of $1.22 billion, a P/E ratio of 86.26, a P/E/G ratio of 3.54 and a beta of 1.48. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, analysts expect that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s payout ratio is 95.65%.

Insider Activity at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 1.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in shares of U.S. Physical Therapy by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company’s stock valued at $96,179,000 after acquiring an additional 6,393 shares in the last quarter. Copeland Capital Management LLC grew its holdings in U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after buying an additional 72,715 shares during the last quarter. State Street Corp grew its holdings in U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares during the last quarter. Southernsun Asset Management LLC grew its holdings in U.S. Physical Therapy by 4.5% in the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company’s stock valued at $50,725,000 after buying an additional 24,698 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in U.S. Physical Therapy by 1.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company’s stock valued at $37,818,000 after buying an additional 7,890 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.